Sandwich immunoassay for identifying partial proANP peptides

Details Sandwich immunoassay for identifying partial proANP peptides Sandwich immunoassay for identifying partial proANP peptides

2011-07-12

2011-07-12

Yang, Nelson (Department: 1641)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Preparing compound containing saccharide radical

C435S007940, C436S518000, C436S164000

Reexamination Certificate

active

07977072

ABSTRACT:
Disclosed is an improved sandwich immunoassay for identifying partial proANP peptides in cardiac and sepsis diagnosis by using two antibodies which specifically bond to partial sequences in the mid-regional area of NT-proANP, extending from amino acid 53 to amino acid 83 of NT-proANP.

REFERENCES:
patent: 5498524 (1996-03-01), Hall
patent: WO 00/19207 (2000-04-01), None
Missbichler et al. “Sandwich ELISA for proANP 1-98 facilitates investigation of left ventricular dysfunction” Eur J Med Res. Mar. 26, 2001;6(3):105-11.
Arnlov et al. “N-terminal atrial natriuretic peptide and left ventricular geometry and function in a population sample of elderly males” J Intern Med. Jun. 2000;247(6):699-708.
Merck Manuals Online Medial Library, section index for “Heart and Blood Vessel Disorders”; Home Edition, retrieved from www.merck.com/mmhe on Mar. 29, 2008.
Bast et al. “Translational Crossroads for Biomarkers” Clin Cancer Res 2005; 11(17), 6103-6108.
LaBaer et al. “So, You Want to Look for Biomarkers” Journal of Proteome Research 2005; 4, 1053-1059.
Baker “In Biomarkers We Trust?” Nature Biotechnology 2005; 23(3), 297-304.
Derwent, partial abstract translation for WO-00/19207 (5 pages), retrieved via East on Feb. 20, 2009.
Harlow & Lane “Antibodies: A Laboratory Manual”, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1988, pp. 23-24, 76, and 578.
The Academic Press Dictionary of Science and Technology (definition for the term “polyclonal”; Oxford: Elsevier Science & Technology (1996); retrieved Oct. 22, 2008, from http://www.credoreference.com/entry/3144515/.
Janeway et al. Immunobiology: the Immune System in Health and Disease (1999), Elsevier Science Ltd/Garland Publishing, New York, NY, Fourth Edition, pp. 34-35.
Wolfe, S.L., Molecular and Cellular Biology, 1993, pp. 790-793.
Mathis et al. “Probing Molecular Interactions with Homogeneous Techniques Based on Rare Earth Cryptates and Fluorescence Energy Transfer” Clin. Chem. 41/9, 1391-1397 (1995).
Macaulay Hunter et al., “Analysis of peptides derived from Pro Atrial Natriuretic Peptide that circulate in man and increase in heart disease,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 58, No. 3, pp. 205-216 (1998) Abstract Only attached.
Morgenthaler et al., “Immunoluminometric Assay for the Midregion of Pro-Atrial Natriuretic Peptide in Human Plasma,” Clinical Chemistry, vol. 50, No. 1, pp. 234-236 (2004).
Itoh et al., “Peptides derived from atrial natriuretic polypeptide precursor in human and monkey brains,” Journal of Hypertension, 6 (suppl 4) pp. S309-S319 (1988).
Meleagros et al., “Pro-Atrial Natriuretic Peptide (1-98): The Circulating Cardiodilatin in Man,” Peptides, 10, pp. 545-550 (1989).
Buckley, et al., “Concentrations of N-terminal ProANP in human plasma: evidence for ProANP (1-98) as the circulating form,” Clinica Chimica Acta, 191, pp. 1-14 (1990).
Lerman et al., “Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction,” Lancet, 341(8853), pp. 1105-1108 (1993).
Cleland et al., “Stability of plasma concentrations of N and C terminal atrial natriuretic peptides at room temperature,” Heart, 75, pp. 410-413 (1996).
Hansen et al., “Proatrial natriuretic polypeptide (31-67) in healthy individuals: day-to-day variation and influence of sex and age,” Scand J Clin. Lab. Invest., 55, pp. 447-452 (1995).
Overton et al., “Processing of Long-Acting Natriuretic Peptide and Vessel Dilator in Human Plasma and Serum,” Peptides, 17(7), pp. 1155-1162 (1996).
Daggubati et al., “Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators,” Cardiovascular Research, 36, pp. 246-255 (1997).
Buckley et al., “Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice,” Clinical Science, 97, pp. 689-695 (1999).
Klinge et al., “N-terminal proatrial natriuretic peptide in angina pectoris: impact of revascularization by angioplasty,” International Journal of Cardiology, 68, pp. 1-8 (1999).
Holmstrom et al., “Plasma levels of N-terminal proatrial natriuretic peptide in children are dependent on renal function and age,” Scand J Clin Lab Invest, 60, pp. 149-159 (2000).
Franz et al., “N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment,” Kidney International, 58, pp. 374-383 (2000).
Hamer et al., “Enzyme Immunoassays for Fragments (Epitopes) of Human Proatrial Natriuretic Peptides,” Clin Chem Lab Med, 38(1), pp. 27-32 (2000).
Cappellin et al, “Plasma atrial natriuretic peptide (ANP) fragments proANP (1-30) and proANP (31-67) measurements in chronic heart failure: a useful index for heart transplantation?,” Clinica Chimica Acta, 310, pp. 49-52 (2001).
Jernberg et al., “Usefulness of Plasma N-Terminal Proatrial Natriuretic Peptide (proANP) as an Early Predictor of Outcome in Unstable Angina Pectoris or Non-ST-Elevation Acute Myocardial Infarction,” The American Journal of Cardiology, 89, pp. 64-66 (2002).
Stridsberg et al., “A Two-site Delfia Immunoassay for Measurements of the N-terminal Peptide of pro-Atrial Natriuretic Peptide (nANP),” Upsala J. Med. Sci., 102, pp. 99-108 (1997).
Mitaka et al., “Plasma α-atrial natriuretic peptide concentrations in acute respiratory failure associated with sepsis: Preliminary study,” Critical Care Medicine, 18(11), pp. 1201-1203, 1990.
Mitaka et al., “Endothelin-1 and atrial natriuretic peptide in septic shock,” American Heart Journal, 126(2), pp. 466-468 (1993).
Marumo et al., “A Highly Sensitive Radioimmunoassay of Atrial Natriuretic Peptide (ANP) in Human Plasma and Urine,” Biochemical and Biophysical Research Communications, 137(1), pp. 231-236 (1986).
Aiura et al., “Circulating concentrations and physiologic role of atrial natriuretic peptide during endotoxic shock in the rat,” Critical Care Medicine, 23, pp. 1898-1906 (1995).
Mazul-Sunko et al., “Pro-atrial natriuretic peptide hormone from right atria is correlated with cardiac depression in septic patients,” J. Endocrinol. Invest., 24, RC22-RC24 (2001).
Hartemink et al., “α-Atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock,” Critical Care Medicine, 29(1), pp. 80-87 (2001).
Kiemer et al., “The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages,” Ann Rheum Dis, 60, iii68-iii70 (2001).
Kiemer -et al., “The Atrial Natriuretic Peptide as a Regulator of Kupffer Cell Functions,” Shock, 17(5), pp. 365-371 (2002).
Kiemer et al., “Induction of Iκb: atrial natriuretic peptide as a regulator of the NF-κB pathway,” Biochemical and Biophysical Research Communications, 295, pp. 1068-1076 (2002).
Buckley etal., “N-terminal pro atrial natriuretic peptide in human plasma,” Am. J. Hypertens, 3 (12) Pt. (1), pp. 933-935 (1990).

Affiliated with

Also associated with

Rating

Sandwich immunoassay for identifying partial proANP peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sandwich immunoassay for identifying partial proANP peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sandwich immunoassay for identifying partial proANP peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2708817